<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Health · Newsline Post</title><link>https://newslinepost.com/en/section/salud/</link><description>All the health coverage from Newsline Post, with context and rigour.</description><language>en</language><atom:link href="https://newslinepost.com/en/section/salud/feed.xml" rel="self" type="application/rss+xml"/><item><title>FDA orders warning of possible vision loss for Ozempic and all GLP-1 drugs</title><link>https://newslinepost.com/en/2026/11/09/fda-requires-vision-loss-warning-glp-1-drugs/</link><guid>https://newslinepost.com/en/2026/11/09/fda-requires-vision-loss-warning-glp-1-drugs/</guid><pubDate>Mon, 09 Nov 2026 22:07:20 GMT</pubDate><description>The US agency is requiring makers of all GLP-1 drugs, such as Wegovy, Mounjaro and Zepbound, to add a warning about a rare optic nerve injury to their labels.</description><category>Health</category></item></channel></rss>
